Traditional TMS treatment evaluation has long relied on symptom scales and patient-reported outcomes, tools that are valuable but that stop short of directly measuring what is happening in the brain. Firefly Neuroscience’s quantitative EEG brain mapping platform changes that equation, giving clinicians objective, physiologic data before and after treatment to document neurological change alongside clinical improvement.

This case study walks through two real-world patient cases, one involving depression and anxiety and another involving depression with attention and focus symptoms, showing how baseline and follow-up brain mapping captured measurable changes in brain activity following TMS therapy. In both cases, electrophysiologic normalization was observed in the specific regions targeted during stimulation, providing a level of treatment validation that symptom questionnaires alone cannot offer.

Whether you are looking to strengthen clinical documentation, improve patient communication, or build a more structured monitoring workflow into your TMS practice, see what is possible when objective brain measurement is part of the process. Download the case study to see the data for yourself.